Literature DB >> 29771787

Brief Report: Point of Care Cryptococcal Antigen Screening: Pipetting Finger-Prick Blood Improves Performance of Immunomycologics Lateral Flow Assay.

Rachel M Wake1,2, Joseph N Jarvis3,4,5, Thomas S Harrison2,6, Nelesh P Govender1,7,8.   

Abstract

BACKGROUND: Cryptococcal antigen (CrAg) screening at the point of care could improve cryptococcal meningitis prevention where laboratory resources are limited. We evaluated the accuracy of Immunomycologics (IMMY, Norman, OK) CrAg lateral flow assay (LFA) using different techniques at point of care.
SETTING: Two tertiary-level hospitals in Johannesburg and a community health clinic in Soweto, South Africa.
METHODS: A case-control diagnostic validation study and a prospective clinic-based implementation study using the IMMY CrAg LFA on finger-prick blood. Accuracy, using direct application of LFA to sample, or pipette to transfer sample to diluent, and reading after 10 and 20 minutes, was compared with laboratory-based plasma testing.
RESULTS: The validation study tested 64 CrAg-positive and 152 CrAg-negative patients with no symptoms or signs of meningitis, identified by routine laboratory screening, recruited by convenience sampling. Consecutively diagnosed HIV-infected adults (n = 654) were included in the implementation study. Sensitivity was 82% and 20% when the LFA was read 10 minutes after direct application to finger-prick blood in the validation and implementation studies, respectively. Using a pipette to transfer blood and reading after 20 minutes improved sensitivity to 100%, while retaining 100% specificity, in both studies.
CONCLUSIONS: Although the IMMY CrAg LFA performs well when applied directly to finger-prick blood for diagnosing cryptococcal meningitis, this technique may not provide adequate volume to detect low concentrations of CrAg when screening asymptomatic patients. Using a pipette to transfer larger volumes of blood to diluent before CrAg LFA testing and reading results after 20 minutes is a more reliable point-of-care method.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29771787      PMCID: PMC6381996          DOI: 10.1097/QAI.0000000000001721

Source DB:  PubMed          Journal:  J Acquir Immune Defic Syndr        ISSN: 1525-4135            Impact factor:   3.731


  13 in total

Review 1.  Case-control and two-gate designs in diagnostic accuracy studies.

Authors:  Anne W S Rutjes; Johannes B Reitsma; Jan P Vandenbroucke; Afina S Glas; Patrick M M Bossuyt
Journal:  Clin Chem       Date:  2005-06-16       Impact factor: 8.327

2.  False-Negative Serum Cryptococcal Lateral Flow Assay Result Due to the Prozone Phenomenon.

Authors:  Gar-Hing Lee; Ian Arthur; Michael Leung
Journal:  J Clin Microbiol       Date:  2018-03-26       Impact factor: 5.948

3.  Monoclonal antibodies specific for immunorecessive epitopes of glucuronoxylomannan, the major capsular polysaccharide of Cryptococcus neoformans, reduce serotype bias in an immunoassay for cryptococcal antigen.

Authors:  Ann Percival; Peter Thorkildson; Thomas R Kozel
Journal:  Clin Vaccine Immunol       Date:  2011-06-22

4.  Cryptococcal meningitis screening and community-based early adherence support in people with advanced HIV infection starting antiretroviral therapy in Tanzania and Zambia: an open-label, randomised controlled trial.

Authors:  Sayoki Mfinanga; Duncan Chanda; Sokoine L Kivuyo; Lorna Guinness; Christian Bottomley; Victoria Simms; Carol Chijoka; Ayubu Masasi; Godfather Kimaro; Bernard Ngowi; Amos Kahwa; Peter Mwaba; Thomas S Harrison; Saidi Egwaga; Shabbar Jaffar
Journal:  Lancet       Date:  2015-03-10       Impact factor: 79.321

5.  Prognosis of HIV-1-infected patients starting highly active antiretroviral therapy: a collaborative analysis of prospective studies.

Authors:  Matthias Egger; Margaret May; Geneviève Chêne; Andrew N Phillips; Bruno Ledergerber; François Dabis; Dominique Costagliola; Antonella D'Arminio Monforte; Frank de Wolf; Peter Reiss; Jens D Lundgren; Amy C Justice; Schlomo Staszewski; Catherine Leport; Robert S Hogg; Caroline A Sabin; M John Gill; Bernd Salzberger; Jonathan A C Sterne
Journal:  Lancet       Date:  2002-07-13       Impact factor: 79.321

6.  Point-of-Care Testing for Cryptococcal Disease Among Hospitalized Human Immunodeficiency Virus-Infected Adults in Ethiopia.

Authors:  Admasu Tenna Mamuye; Ethan Bornstein; Obsie Temesgen; Henry M Blumberg; Russell R Kempker
Journal:  Am J Trop Med Hyg       Date:  2016-08-15       Impact factor: 2.345

7.  High Cryptococcal Antigen Titers in Blood Are Predictive of Subclinical Cryptococcal Meningitis Among Human Immunodeficiency Virus-Infected Patients.

Authors:  Rachel M Wake; Erika Britz; Charlotte Sriruttan; Ivy Rukasha; Tanvier Omar; David C Spencer; Jeremy S Nel; Sello Mashamaite; Adeboye Adelekan; Tom M Chiller; Joseph N Jarvis; Thomas S Harrison; Nelesh P Govender
Journal:  Clin Infect Dis       Date:  2018-02-10       Impact factor: 9.079

Review 8.  Early mortality in adults initiating antiretroviral therapy (ART) in low- and middle-income countries (LMIC): a systematic review and meta-analysis.

Authors:  Amita Gupta; Girish Nadkarni; Wei-Teng Yang; Aditya Chandrasekhar; Nikhil Gupte; Gregory P Bisson; Mina Hosseinipour; Naveen Gummadi
Journal:  PLoS One       Date:  2011-12-29       Impact factor: 3.240

9.  Evaluation of fingerstick cryptococcal antigen lateral flow assay in HIV-infected persons: a diagnostic accuracy study.

Authors:  Darlisha A Williams; Tadeo Kiiza; Richard Kwizera; Reuben Kiggundu; Sruti Velamakanni; David B Meya; Joshua Rhein; David R Boulware
Journal:  Clin Infect Dis       Date:  2015-04-01       Impact factor: 9.079

10.  Cryptococcal antigen screening by lay cadres using a rapid test at the point of care: A feasibility study in rural Lesotho.

Authors:  Fernanda Rick; Aline Aurore Niyibizi; Amir Shroufi; Kazumi Onami; Sarah-Jane Steele; Malehlohonolo Kuleile; Innocent Muleya; Tom Chiller; Tiffany Walker; Gilles Van Cutsem
Journal:  PLoS One       Date:  2017-09-06       Impact factor: 3.240

View more
  9 in total

1.  Cryptococcal-related Mortality Despite Fluconazole Preemptive Treatment in a Cryptococcal Antigen Screen-and-Treat Program.

Authors:  Rachel M Wake; Nelesh P Govender; Tanvier Omar; Carolina Nel; Ahmad Haeri Mazanderani; Aaron S Karat; Nazir A Ismail; Caroline T Tiemessen; Joseph N Jarvis; Thomas S Harrison
Journal:  Clin Infect Dis       Date:  2020-04-10       Impact factor: 9.079

Review 2.  Cryptococcal Meningitis Diagnostics and Screening in the Era of Point-of-Care Laboratory Testing.

Authors:  Radha Rajasingham; Rachel M Wake; Tafese Beyene; Andrew Katende; Emilio Letang; David R Boulware
Journal:  J Clin Microbiol       Date:  2019-01-02       Impact factor: 5.948

3.  High prevalence of Cryptococcal antigenemia using a finger-prick lateral flow assay in individuals with advanced HIV disease in Santarém Municipality, Brazilian Amazon Basin.

Authors:  João Guilherme Pontes Lima Assy; Renato do Carmo Said; Olivia Campos Pinheiro; Alisson Dos Santos Brandão; David R Boulware; Francisco Oscar de Siqueira França; José Ernesto Vidal
Journal:  Med Mycol       Date:  2021-09-03       Impact factor: 4.076

Review 4.  Cryptococcal meningitis: a review for emergency clinicians.

Authors:  Kathryn Marie Fisher; Tim Montrief; Mark Ramzy; Alex Koyfman; Brit Long
Journal:  Intern Emerg Med       Date:  2021-01-09       Impact factor: 3.397

Review 5.  Small-volume detection: platform developments for clinically-relevant applications.

Authors:  Wei-Hsuan Sung; Yu-Ting Tsao; Ching-Ju Shen; Chia-Ying Tsai; Chao-Min Cheng
Journal:  J Nanobiotechnology       Date:  2021-04-21       Impact factor: 10.435

6.  Performance of non-laboratory staff for diagnostic testing and specimen collection in HIV programs: A systematic review and meta-analysis.

Authors:  Lara Vojnov; Miriam Taegtmeyer; Caroline Boeke; Jessica Markby; Lindsay Harris; Meg Doherty; Trevor Peter; Nathan Ford
Journal:  PLoS One       Date:  2019-05-02       Impact factor: 3.240

Review 7.  Diagnosis and Management of Central Nervous System Cryptococcal Infections in HIV-Infected Adults.

Authors:  Caleb Skipper; Mahsa Abassi; David R Boulware
Journal:  J Fungi (Basel)       Date:  2019-07-19

8.  Diagnostic Accuracy of Point of Care Cryptococcal Antigen Lateral Flow Assay in Fingerprick Whole Blood and Urine Samples for the Detection of Asymptomatic Cryptococcal Disease in Patients with Advanced HIV Disease.

Authors:  Kathryn Boyd; Vinie Kouamou; Admire Hlupeni; Zorodzai Tangwena; Chiratidzo E Ndhlovu; Azure T Makadzange
Journal:  Microbiol Spectr       Date:  2022-08-04

9.  Evaluation of a Novel Semiquantitative Cryptococcal Antigen Lateral Flow Assay in Patients with Advanced HIV Disease.

Authors:  Joseph N Jarvis; Mark W Tenforde; Kwana Lechiile; Thandi Milton; Amber Boose; Tshepo B Leeme; Leabaneng Tawe; Charles Muthoga; Ivy Rukasha; Fredah Mulenga; Ikanyeng Rulaganyang; Mooketsi Molefi; Síle F Molloy; Julia Ngidi; Thomas S Harrison; Nelesh P Govender; Madisa Mine
Journal:  J Clin Microbiol       Date:  2020-08-24       Impact factor: 5.948

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.